Continuous Versus Intermittent Infusion of Beta-Lactam Antibiotics: Where Do We Stand Today? A Narrative Review
Abstract
Share and Cite
Alawyia, B.; Fathima, S.; Spernovasilis, N.; Alon-Ellenbogen, D. Continuous Versus Intermittent Infusion of Beta-Lactam Antibiotics: Where Do We Stand Today? A Narrative Review. GERMS 2024, 14, 162-178. https://doi.org/10.18683/germs.2024.1428
Alawyia B, Fathima S, Spernovasilis N, Alon-Ellenbogen D. Continuous Versus Intermittent Infusion of Beta-Lactam Antibiotics: Where Do We Stand Today? A Narrative Review. GERMS. 2024; 14(2):162-178. https://doi.org/10.18683/germs.2024.1428
Chicago/Turabian StyleAlawyia, Basil, Sarah Fathima, Nikolaos Spernovasilis, and Danny Alon-Ellenbogen. 2024. "Continuous Versus Intermittent Infusion of Beta-Lactam Antibiotics: Where Do We Stand Today? A Narrative Review" GERMS 14, no. 2: 162-178. https://doi.org/10.18683/germs.2024.1428
APA StyleAlawyia, B., Fathima, S., Spernovasilis, N., & Alon-Ellenbogen, D. (2024). Continuous Versus Intermittent Infusion of Beta-Lactam Antibiotics: Where Do We Stand Today? A Narrative Review. GERMS, 14(2), 162-178. https://doi.org/10.18683/germs.2024.1428